Harbin Clinic

Rome, Georgia 30165-1698

2 studies enrolling now · 25 studies all time

What they study most

Acute Gout, Advanced Prostate Cancer, Arthritis, Rheumatoid, Arthroscopic Surgical Treatment of High-grade (>50%) Partialthickness, Atherosclerosis, Breast Neoplasms, Cataract, Chemotherapy-induced Nausea and Vomiting, Congestive Heart Failure, Coronary Artery Disease, Degenerative and Traumatic Pathology of the Foot and Ankle, Degenerative and Traumatic Pathology of the Hand and Wrist

Studies at this site

• Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears — Recruiting now
• Integrity Implant System Post Market Clinical Follow-Up Study — Recruiting now
• A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer — Running, not enrolling
• REGENETEN™ Bioinductive Implant System in Full-thickness Tears — Stopped early
• Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study — Stopped early
• Treatment of Partial-Thickness Rotator Cuff Tears — Stopped early
• Web Based Orthopaedic Sports Medicine Registry — Stopped early
• A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure — Completed
• Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study — Completed
• Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase — Completed
• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab — Stopped early
• An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine — Completed
• A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer — Completed
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — Completed
• Eslicarbazepine Acetate Monotherapy Long Term Study — Completed
• A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). — Completed
• A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors — Completed
• Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs — Completed
• Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL — Completed
• Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study. — Completed
• Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients — Completed
• ARISE - Aggressive Reduction of Inflammation Stops Events — Status unconfirmed
• A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs — Status unconfirmed